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HUGGINS, GRAND AND BRILLANTES (1961) demonstrated that mammary
tumours could be induced by a single administration ofthe polycycic hydrocarbon
9,10-dimethyl-1,2-benzanthracene (DMBA). In contrast with many other
carcinogens DMBA has a short induction period and tumours appear within 2 to
3 months. The mammary lesions so induced are hormone-dependent. Regres-
sion or disappearance ofthe tumours can be effected by hypophysectomy (Daniel
and Prichard, 1963), oophorectomy (Young, Cowan and Sutherland, 1963) or by
the exhibition of exogenous steroids, particularly combinations of oestrogen and
progesterone (Huggins and Yang, 1962). This experimental tumour system thus
provides a useful model for the evaluation of endocrine factors concerned in the
induction and maintenance of mammary neoplasms.
DMBA-induced tumours have been classified either according to their growth
characteristics (Young and Cowan, 1963; Stevens, Stevens and Currie, 1965) or on
the basis oftheir histological appearance (Daniel and Prichard, 1964; Gruenstein,
Meranze, Thatcher and Shimkin, 1966). In the present investigation the tumours
have been classified into two broad histological groups-" simple ", fibroadeno-
mata, and " malignant ", adenocarcinomata. It has been found that there are
endocrine organ differences between groups. Rats bearing simple tumours are
characterized by having lighterovaries andheavier pituitaries than the malignant-
tumour-bearing and control groups. The striking histological features of the
ovaries of simple tumour-bearing rats are follicular cystic changes and relative
absence of corpora lutea.
MATERIALS AND METHOD
Female albino rats of the Sprague-Dawley strain (Oxford Laboratory Animal
Colonies, Manor Cottage Stratton Audley, Bicester, Oxfordshire) were used and
on their 50th day of life DMBA (K and K Laboratories Inc., 121 Express St.,
Engineers Hill, Plainview, New York 11803, U.S.A.) dissolved in sesame oil was
administered by intragastric instillation to 6 groups ofrats (20 animals per group).
The effects of a range of doses from 20 mg. to 70 mg., by 10 mg. increments, was
studied. Diet consisted of standard rat cake (Macgregor and Co. (Leith) Ltd.,
Quayside Mills, Leith, Scotland) and water was provided ad libitum. Control rats
were maintained under the same conditions but were not exposed to the carcino-
gen.
Eight months after the administration ofthe hydrocarbon the rats were killed
by decapitation. The tumours, adrenals, ovaries and pituitaries were weighed
before fixation and stained with haematoxylin and eosin.ENDOCRINE DIFFERENCES IN RATS WITH MAMMARY TUMOURS
RESULTS
DMBA toxicity
Of the 120 experimental rats, 34 (28.3 per cent) died within the first 10 days
from the toxic effects of DMBA. The striking necrotic effect of DMBA on the
adrenal cortex described by Huggins and Morrii (1961) was seen in all ofthese rats.
There was a progressive increase in mortality with increasing dose ofthe carcino-
gen; all rats survived 20 mg. but more than 50 per cent succumbed after 60 mg.
and 70 mg. (Table I).
Tumour yield
Only 44 (53 per cent) of the 86 surviving rats had mammary tumours at
autopsy. The tumour yield in terms of the number of rats with tumours im-
proved with increase in the dose of DMBA (Table I, col. 3). Such benefit was
offset, however, by therising mortality rate. Among the dosegroups there was no
significant difference in the average number of tumours per rat (Table T, col. 5).
No tumours occurred in the 10 control rats.
TABLE I.-Mortality and Tumour Yield after Administration of
Increasing Doses ofDMBA
Dosage
DMBA Mortality Tumour-bearing rats Total No. Average No. of
(mg.) (percentage) (per cent survivors) of tumours tumours/rat
20 . Nil . 7/20 (35%) 17 . 2.4
30 . 1/20 (5%) . 8/19 (42%) . 15 . 1.9
40 . 4/20 (20%) . 6/16 (37.5%) 20 . 3-3
50 . 7/20 (35%) . 8/13 (61.5%) . 13 . 16
60 . 11/20 (55%) . 7/9 (78%) . 11 1*6
70 . 11/20 (55%) . 8/9 (89%) . 23 2 - 9
Total . 34/120 (28-3%) . 44/86 (53%) . 99 . 22
Histology of mammary tumours
On the basis of their histological appearance the tumours were classified into
simple and malignant groups. The simple tumours were fibroadenomata and a
typical example is seen in Fig. 1.
The malignant tumours were adenocarcinomata similar to those reported by
other workers and generally regarded as mammary cancers (Young, Cowan and
Sutherland, 1963; Stevens, Stevens and Currie, 1965; Gruenstein, Meranze,
Thatcher and Shimkin, 1966). For descriptive purposes the groups were desig-
nated as simple, malignant, non-tumour-bearing and control groups. The findings
are set out in Table II.
TABLE II.-Distribution ofSimple and Malignant Tumours
Dosage Rats with tumours Total number oftumours
DMBA
(mg.) Simple Malignant Simple Malignant
20 . 3 4 . 3 14
30 . 0 8 . 0 15
40 . 1 5 . 1 19
50 . 3 5 . 3 10
60 . 0 7 . 0 11
70 . 1 7 . 1 22
Total . 8 36 . 8 91
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There were 8 rats with solitary fibroadenomata and these constitute the simple
group. Ofthe 36 rats inthe malignant group, all had atleastoneadenocarcinoma;
18 had two or more, and 10 bore both malignant and simple tumours. There
were 74 malignant and 17 simple tumours in the 91 mammary lesions in this
group.
Among the adenocarcinomata variable degrees of differentiation were seen
between the tumours and in different areas ofthe same tumour. The predominant
type was an adenocarcinoma ofvariable degree ofdifferentiation (Fig. 2). Mitotic
figures were evident in some of the tumours (Fig. 3). A number had papillary
outgrowths projecting into the lumina of thin-walled ducts contained in an
abundant fibrous stroma (Fig. 4).
Endocrine organ weights
The weights of ovaries, adrenals and pituitaries were corrected for variations
in weight of the rats and expressed as mg./100 g. body weight. An unexpected
result was the finding that the ovaries and pituitaries of rats bearing simple
tumours differed significantly from those of the malignant group (Table Ill).
The ovaries were lighter (P < 0.01) and the pituitaries heavier (P < 0.0025) in the
simple group. There was no significant difference in adrenal weights.
TABLE III.-CoMparison of Mean Endocrine Organ Weights Between
Simple and Malignant Tumour-bearing Rats
Tumour type Ovaries Adrenals Pituitary
(No. of rats) mg./100 g. mg./100 g. mg./100 g.
Simple (8). 17*76±3*86 . 23*83+592 5*78±O*48
Malignant (36) . 24-45±726 2368±6-60 . 4-52±108
" t " Test. . P<O01 . Not significant . P<O.0025
Further analysis (Table IV) revealed that such differences in ovaries and pitui-
taries distinguished simple tumour-bearing rats not only from the malignant
group but also from non-tumour-bearing and control groups.
Solitary fibroadenomata appeared in a random manner among the dose groups
(Table V). The characteristic ovarian and pituitary weight pattern occurred in
every group in which simple tumours appeared and is thus independent of the
dose administered.
EXPLANATION OF PLATES.
FIG. 1.-Fibroadenoma. Thin-walled duct in fibrous tissue containing small ductules and a
few acini. H. and E. x 100.
FIG. 2.--Adenocarcinoma. Poorly differentiated with acinar formation. Acini lined by
single layer of cells exhibiting nuclear pleomorphism. H. and E. X 250.
FIG. 3.-Poorly differentiated adenocarcinoma. Tubules lined by several layers of cells with
numerous mitotic figures. H. and E. x 615.
FIG. 4.-Papillary adenocarcinoma projecting into duct lined by singlelayer of flattened cells.
H. andE. x100.
FIG. 5.-Ovary from rat with adenocrcinoma. Well-marked corpora lutea and few follicles.
H. and E. x 100.
FIG. 6.-Ovary from rat with fibroadenoma of breast. Large cystic follicles numerous
smaller follicles in various stages of development, scanty interstitial tissue and few corpora
lutea. H. and E. x 100.
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TABLE IV.-Comparison of Mean Endocrine Organ Weights Between
Simple Tumour-bearing Rats and the Other Groups
In the statistical evaluation the simple tumour-bearing group was compared
independently with each ofthe other groups.
Type Ovaries Adrenals Pituitary
(No. of rats) mg./100 g. mg./100 g. mg./100 g.
Malignant (36). . 24.45±7i26* . 2368i±6e60* . 4.52±1.08*
No tumours (42) . 22.30±5.08t . 20.11±3.88* 4.7791o02t
Controls (10) . . 23 50±4.64t . 23.46±6.42* . 4.8640.85t
Simple (8) . . 17*76±3 86 . 23 83±5 92 . 5.7850.48
*P<O.01 *Not significant * P<0 0025
tP<0.0125 tP<0-0005
tP<0-01 JP<O0025
TABLE V.-Mean Weights of Endocrine Organs, in mg./100g. Body Weight, of
Rats Bearing Simple or Malignant Tumour8
The figures in brackets in columns 2 and 3 indicate the number of rats in each
group. The pattern of lighter ovaries and heavier pituitaries is apparent in
each group in which simple tumours appeared
Dosage Ovaries Adrenals Pituitary
DMBA A A A
(mg.) Simple Malignant Simple Malignant Simple Malignant
20 . 18-33 (3) 27.26 (4) . 21.91 26*57 . 5*81 4.75
30 . - 25-35 (8) . - 19-88 . - 5*20
40 21.20 (1) 26.79 (5) . 17-88 20-79 . 4*78
50 . 16.90 (3) 24.10 (5) . 26-71 29-80 . 5 93 3-86
60 . - 23.10 (7) . - 23-11 . 3-92
70 14.98 (1) 22.37 (7) . 26*89 33X32 . 5-23 4.48
Mean wts. 17 76 24.45 . 23.83 23 68 . 5.78 4 52
Histology of endocrine organs
Ovaries.-The appearance of the ovaries from non-tumour-bearing, malignant
and control groups were essentially similar. The features ofwell-defined corpora
lutea and a few small follicles are seen in Fig. 5. In contrast, the appearances
seen in Fig. 6 were observed in 6 of the 8 rats with solitary fibroadenomata.
The characteristic features are relative absence of corpora lutea, several follicular
cysts, small follicles in various stages ofdevelopment and scanty interstitial tissue.
Such ovaries were seen in only 7 ofthe 36 rats with malignant tumours, in 2 ofthe
44 non-tumour-bearing rats and in none ofthe 10 rats in the control group.
Pituitaries and adrenals.-No obvious differences in histological features ofthe
pituitaries stained by haematoxylin and eosin were detected among the groups.
The adrenal histology was similar in all but the control groups in which there was
no evidence ofthe regeneration nodules observed in those which had been exposed
to the adrenolytic effects of the carcinogen.
DISCUSSION
The primary aim of this investigation was to establish the most suitable dose
of DMBA for subsequent endocrinological and biochemical investigations of the
tumour system. From evaluation of the data of the tumour yield and of the
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toxicity ofthe carcinogen 30 mg. DMBA is now regarded as the most suitable dose
for this laboratory.
The appearance of solitary fibroadenomata in a number of rats provided an
interesting group for comparative studies. Spontaneous development of fibro-
adenoma is a feature of elderly female Sprague-Dawley rats but this rarely occurs
before the age of 18 months (Benson, Lev and Grand, 1956). No tumours
appeared in the control group during the investigation which was completed before
the animals were 10 months old. It is concluded, therefore, that the tumours
were induced by the carcinogen.
Several workers have recorded the appearance of fibroadenomata in response
to the administration of DMBA. Daniel and Prichard (1964) designated 60 of
137 DMBA-induced tumours as being of this histological type. Gruenstein and
his colleagues (1966) reported 15 fibroadenomata among 83 tumours in Sprague-
Dawley rats exposed to either 15 mg. or 20 mg. of DMBA. In the present study
a total of 25 fibroadenomata were found among 99 mammary tumours.
The induction of tumours primarily of connective tissue origin in some animals
and of epithelial tumours in others is a striking biological phenomenon which
invites speculation on possible aetiological mechanisms. The distinguishing
features ofthe ovaries andpituitaries ofsimple tumour-bearing rats which have been
described above are but crude parameters of endocrine status. Nonetheless they
indicate significant differences from the other experimental groups. We favour
the view that these features reflect inherent endocrinological differences among the
rats with consequent variation in response of the endocrine organs and mammary
glands to the effects of the carcinogen. The fact that neither the ovarian nor the
pituitary changes characteristic of the simple tumour-bearing group were seen in
any of the control rats suggests that the primary action of the carcinogen is upon
these organs.
The actions of pituitary hormones on the ovary have been assessed by experi-
ments on hypophysectomised animals and reviewed by Chester-Jones and Ball
(1962). The prime action of pituitary follicle-stimulating-hormone (FSH) is
upon follicular development through a cycle of maturation and atresia without
luteal formation (Greep, van Dyke and Chow, 1942). Under the influence of
FSH the notable ovarian features are large stimulated follicles and deficiency of
interstitial tissue. In contrast the salient effect of luteinising hormone (LH)
is stimulation of interstitial cells without follicular maturation (Simpson, Li and
Evans, 1942). Maturation of follicles, ovulation, secretion of oestrogen and
formation of corpora lutea are dependent upon combinations of suitable amounts
of FSH and LH (Leonora, McShan and Meyer, 1958). The role of prolactin in
maintaining functional corpora lutea has been demonstrated by Everett (1956).
The follicular appearance of ovaries from the simple tumour-bearing group,
the relative absence of corpora lutea and scanty interstitial tissue suggest excessive
stimulation by FSH and deficiency of LH and prolactin.
For the full development of mammary duct and acinar systems oestrogen,
progesterone, prolactin and growth hormone are required (Lyons, Li and Johnson,
1958). It is suggested, therefore, that a primary effect of the carcinogen upon
pituitary and ovaries might produce a deficiency of these hormones. The conse-
quent failure of mammary epithelial elements in these circumstances could result
in the induction of connective tissue tumours in the breast, either as a direct
response to the carcinogen or as a secondary feature of endocrine imbalance.
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Experiments to test this hypothesis of the relationships between pituitary
gonadotrophins, ovarian steroidogenesis and the tumour type are currently being
done.
SUMMARY
1. The effect of increasing doses of DMBA on tumour yield and mortality of
Sprague-Dawley rats was studied.
2. The induced tumours were classified on the basis oftheir histological features
into a simple group (fibroadenomata) and malignant group (adenocarcinomata).
3. Simple tumour-bearing rats were characterised by having lighter ovaries
and heavier pituitaries than the other groups. The ovaries were further distin-
guished by follicular changes suggestive of FSH stimulation.
4. Possible aetiological mechanisms for the induction of different types of
tumour are discussed.
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